TargetMol

Veralipride

Product Code:
 
TAR-T7632
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T7632-1mg1mg£118.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7632-2mg2mg£140.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7632-1mL1 mL * 10 mM (in DMSO)£197.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7632-5mg5mg£221.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7632-10mg10mg£324.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7632-25mg25mg£495.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7632-50mg50mg£687.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7632-100mg100mg£938.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7632-500mg500mg£1,797.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Veralipride is an antagonist of D2 receptor.
CAS:
66644-81-3
Formula:
C17H25N3O5S
Molecular Weight:
383.46
Pathway:
Neuroscience; GPCR/G Protein
Purity:
0.9921
SMILES:
COc1cc(cc(C(=O)NCC2CCCN2CC=C)c1OC)S(N)(=O)=O
Target:
Dopamine Receptor

References

David A , , Don R , , Tajchner G , , et al. Veralipride: alternative antidopaminergic treatment for menopausal symptoms[J]. Maturitas, 1988, 10(4):354-354. Melis G B , Gambacciani M , Cagnacci A , et al. Effects of the Dopamine Antagonist Veralipride on Hot Flushes and Luteinizing Hormone Secretion in Postmenopausal Women[J]. Obstetrics and Gynecology, 1988, 72(5).